Filing Details

Accession Number:
0000921895-25-000176
Form Type:
13D Filing
Publication Date:
2025-01-27 19:00:00
Filed By:
BIOTECHNOLOGY VALUE FUND L P
Company:
Xoma Royalty Corp (NASDAQ:XOMA)
Filing Date:
2025-01-28
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
BIOTECHNOLOGY VALUE FUND L P 0 1,450,165 0 1,450,165 1,450,165 12.3%
BVF I GP LLC 0 1,450,165 0 1,450,165 1,450,165 12.3%
BIOTECHNOLOGY VALUE FUND II LP 0 1,532,861 0 1,532,861 1,532,861 13.0%
BVF II GP LLC 0 1,532,861 0 1,532,861 1,532,861 13.0%
Biotechnology Value Trading Fund OS LP 0 0 0 0 0 0%
BVF Partners OS Ltd. 0 0 0 0 0 0%
BVF GP HOLDINGS LLC 0 2,983,026 0 2,983,026 2,983,026 25.3%
BVF PARTNERS L P/IL 0 2,983,026 0 2,983,026 2,983,026 25.3%
BVF INC/IL 0 2,983,026 0 2,983,026 2,983,026 25.3%
LAMPERT MARK N 0 2,983,026 0 2,983,026 2,983,026 25.3%
Filing





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D

 
BIOTECHNOLOGY VALUE FUND L P
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
BVF I GP LLC
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
BIOTECHNOLOGY VALUE FUND II LP
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
BVF II GP LLC
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
Biotechnology Value Trading Fund OS LP
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
BVF Partners OS Ltd.
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
BVF GP HOLDINGS LLC
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
BVF PARTNERS L P/IL
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
BVF INC/IL
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:01/28/2025
 
LAMPERT MARK N
 
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert
Date:01/28/2025